Gastrin-cholecystokinin(B) Receptor Expression in AGS Cells is Associated with Direct Inhibition and Indirect Stimulation of Cell Proliferation Via Paracrine Activation of the Epidermal Growth Factor Receptor
Overview
Affiliations
Background: Activation of the gastrin-cholecystokinin(B) (CCK(B)) receptor stimulates cell proliferation and increases production of ligands for the epidermal growth factor receptor (EGF-R).
Aims: To determine the role of gastrin-CCK(B) activation in stimulation of cell proliferation via paracrine activation of EGF-R.
Methods: AGS cells were transfected with the gastrin-CCK(B) receptor (AGS-G(R) cells) or with green fluorescent protein (AGS-GFP cells). Proliferation was determined by [(3)H] thymidine incorporation, flow cytometry, and cell counting.
Results: Gastrin inhibited proliferation of AGS-G(R) cells by delaying entry into S phase. However, when AGS-G(R) cells were cocultured with AGS-GFP cells, gastrin stimulated proliferation of the latter. Immunoneutralisation and pharmacological studies using metalloproteinase and kinase inhibitors indicated that the proliferative response was mediated by paracrine stimulation of EGF-R and activation of the mitogen activated protein kinase pathway through release of heparin binding EGF.
Conclusions: Gastrin can directly inhibit, and indirectly stimulate, proliferation of gastric AGS cells.
Varga A, Nemeth I, Kemeny L, Varga J, Tiszlavicz L, Kumar D Int J Mol Sci. 2023; 24(23).
PMID: 38069171 PMC: 10706711. DOI: 10.3390/ijms242316851.
Netazepide Inhibits Expression of Pappalysin 2 in Type 1 Gastric Neuroendocrine Tumors.
Lloyd K, Parsons B, Burkitt M, Moore A, Papoutsopoulou S, Boyce M Cell Mol Gastroenterol Hepatol. 2020; 10(1):113-132.
PMID: 32004755 PMC: 7215182. DOI: 10.1016/j.jcmgh.2020.01.010.
Varga A, Kumar J, Simpson A, Dodd S, Hegyi P, Dockray G Physiol Rep. 2017; 5(19).
PMID: 29038353 PMC: 5641928. DOI: 10.14814/phy2.13394.
Gastrin-induced miR-222 promotes gastric tumor development by suppressing p27kip1.
Lloyd K, Moore A, Parsons B, OHara A, Boyce M, Dockray G Oncotarget. 2016; 7(29):45462-45478.
PMID: 27323780 PMC: 5216734. DOI: 10.18632/oncotarget.9990.
Kumar J, Steele I, Moore A, Murugesan S, Rakonczay Z, Venglovecz V Am J Physiol Gastrointest Liver Physiol. 2015; 309(2):G78-86.
PMID: 25977510 PMC: 4504956. DOI: 10.1152/ajpgi.00084.2015.